Edico Genome Raises $22 Million in Series B Financing
New investor Dell Technologies Capital leads round; all existing investors participate SAN DIEGO, May 9, 2017 – Edico Genome announced today it has raised $22 million in a Series B financing to expand market adoption and product development of its DRAGEN™ platform, an end-to-end solution for analysis of next-generation sequencing data. New investor Dell Technologies Capital,... Read more